Rocket Pharmaceuticals Q2 Adj. EPS $(0.37) Misses $0.24 Estimate
Benzinga Newsdesk 2 months ago
NewsEarningsEarnings Misses
Rocket Pharmaceuticals (NASDAQ:RCKT) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $0.24 by 254.17 percent. This is a 40.32 percent increase over losses of $(0.62) per
Rocket Pharmaceuticals (NASDAQ:RCKT) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $0.24 by 254.17 percent. This is a 40.32 percent increase over losses of $(0.62) per share from the same period last year.